Built & deployed · seven clinical tabs live

From a blood draw to a decision, in one platform.

CellWise outsources the wet lab and does the hard part in software: turning a high-dimensional single-cell dataset into a structured, clinician-ready read, with the quality control and population context that makes it defensible.

✓ Built and deployed, not a concept ✓ Seven clinical modules live ✓ Schema-validated, free of AI hallucination
CellWise · Pipeline
Status
Deployed
Modules live
7 / 7
From one PBMC draw
381
biomarkers
Resolution
Single-cell
Health domains
9
risk-rated domains
Sample to decision
Sequencing · single-cell CRO✓
QC + population normalization✓
Seven analysis engines✓
Report + surveillance✓
Precision input to precision output
Raw single-cell expression, delivered as a decision you can act on.
Grounded inreal population datapeer-reviewed researchlegacy single-cell technology
Founding Practitioner Pilot · fifty places

Up to five of your own patients at $2,095 $1,800 each, for Core Plus.

14% below standard Invoiced only for the ones you send.All in: kit, shipping and the blood draw.A sample that fails lab QC is not invoiced.Decide at the end of a 30-day review.
Per patient
$1,800

Core Plus, 14% below the $2,095 standard rate.

How many
One to five

Your own patients. Invoiced only for the ones you send.

Billing
On delivery, net 30

All in: collection kit, shipping and the phlebotomy draw. A failed QC sample is not invoiced.

Your decision
30-day review

Full module access from your last report, then decide whether to carry on.

Fifty founding places.Full pricing and terms
How it works

How a sample becomes a decision.

CellWise stays software-only. The wet lab happens at a CRO; everything that turns raw data into a clinical read happens here.

Step 01

Sequencing

The sample is run through a single-cell licensed CRO. CellWise never touches a wet lab, so there's nothing new to build or staff.

Step 02

QC + normalization

Strict filtering removes apoptotic cells, and MAD statistics normalize the donor against a dynamic population baseline, eliminating batch effects while preserving rare signal.

Step 03

The engines

Seven modules read the cleaned data: phenotyping, the peptide atlas, the aging profile, target mapping, and more.

Step 04

Grounded report

Findings are drafted as a narrative, then reconciled against curated genomic data, population and individual, and held to a strict schema, so every statement is grounded in the data, not model guesswork. The clinician-ready report pipes into your existing portal, with surveillance between screens.

Everything in the portal

Seven modules, one clinical workspace.

Health Analysis ReportIllustrative preview
SemaglutideGLP-1 receptor agonist · mapped with tirzepatide
Strong match
  1. Cell stateInnate inflammation on, in CD14 monocytes
  2. Genes4 move with the state, 1 against
  3. PathwayNF-κB and IL-1β
  4. MechanismLowered IL-1β and TNF in mononuclear cells in a randomised trial; pooled trials lower CRP. Human data
  5. Check firstA recent infection or vaccine, or hard exercise before the draw
In line with the state
IL1B ↑CXCL8 ↑NLRP3 ↑TNF ↑
Moving against it
CCL2 ↓

Read in this patient's CD14 monocytes against people of the same sex in the reference set.

Mechanism: human dataResponse: CellWise prediction, not yet validated
Module 01

Health Analysis Report

The clinical home base: risk-rated health domains, immuno-metabolic phenotyping, and mechanism-based peptide pairing, each call traced from cell state to genes, pathway and mechanism.

Clinicians see
Each peptide call explained: the cell state, the genes moving with it and against it, the pathway, the evidence tier and what to check first.
Licensees get
Report templates in your brand, under co-brand or white-label.
Biomarker AnalyticsIllustrative preview
S100A12
IL1B
ISG15
CCR7
TCF7
PRF1
HSPA5
same-sex reference rangethis patient
Module 02

Biomarker Analytics

The quantitative, visual view of the patient's raw biomarker data, shown as a population-vs-patient overview.

Clinicians see
Every panel gene placed against the same-sex reference population, the outliers first.
Licensees get
The same views themed to your interface, or piped through the API.
Data ExplorerIllustrative preview
IL1B
Cell populationDirectionSignal
CD14 monocytes↑
CD16 monocytes↑
pDCs↑
CD4 T cells·
Module 03

Data Explorer

A filterable, gene-level interface over the patient's complete dataset, exposing the top cell populations carrying each signal.

Clinicians see
Filter by gene, cell type or direction and see which populations carry each signal.
Licensees get
Gene-level data your scientific team can query, not just a PDF.
Clinical Scenario SimulatorIllustrative preview
HypothesisWhat if this patient starts a GLP-1 receptor agonist?
Re-running against this patient's data
Inflammasome tone
Insulin signalling
Interferon response
Module 04

Clinical Scenario Simulator

Test a clinical hypothesis against the patient's own molecular data and re-run it in seconds.

Clinicians see
Pose a clinical hypothesis against the patient's own data and re-run it in seconds.
Licensees get
A consult tool that keeps clinicians working inside your platform.
Outcomes & MonitoringIllustrative preview
BaselineLoadingMaintenance
Peptide-specific labWearable trend (HRV)
Module 05

Outcomes & Monitoring

Assay-independent surveillance across dosing phases, peptide-specific labs, and wearable trends, with no repeat sequence required.

Clinicians see
Peptide-specific labs and wearable trends tracked across dosing phases, between screens.
Licensees get
A monitoring loop that brings patients back to your menu between draws.
Cellular Aging ProfileIllustrative preview
Immune agewhich compartments are aging fastest, and which hallmarks drive it
Genomic instabilityTelomere attritionEpigenetic alterationProteostasisAutophagyNutrient sensingMitochondriaSenescenceStem-cell exhaustionCommunicationInflammationDysbiosis
Module 06

Cellular Aging Profile

Immune age, senescence, and the 12 hallmarks from one PBMC sample, for cell-resolved biological aging.

Clinicians see
Immune age, senescence and the 12 hallmarks of aging from one PBMC sample.
Licensees get
A preventative-health line item you can list under your own name.
Longitudinal ScreeningIllustrative preview
IL1B · CD14 mono
↓
ISG15 · CD16 mono
·
CCR7 · CD4 T
↑
DDIT3 · NK
↓
Screen 1Screen 2
Module 07

Longitudinal Screening

Re-assay a patient and see the gene-expression deltas across key biomarkers, so you see what has shifted since the last screen.

Clinicians see
Re-assay and see exactly which genes moved, in which cells, since the last screen.
Licensees get
Re-assay built into the product, so the second test is part of the plan.
Hover or tap a module to stop on it. Previews are illustrative.
Under the hood

The capability, in numbers.

What the platform reads, ranks, and connects to.

381
Biomarker genes across immune cell populations, the resolution bulk panels average away.
519 alert rules
Post-therapy alert rules across 88 peptides, drawn from regulatory and clinical efficacy data and feeding the live surveillance feed. Compatibility ranking is separate and runs against commercially available peptides.
MAD
Median-absolute-deviation normalization against a population baseline, so results hold across runs.
Schema locked
Every finding is reconciled against curated genomic data and held to a strict JSON schema, so reports render from the data itself, free of AI hallucination.
AI
A scenario simulator anchored to the patient's own molecular data, for hypothesis testing in seconds.
7
Clinical modules, live and deployed today, from the health report to longitudinal screening.
Scope of use

Research use only, and decision support.

Two things about CellWise that are easy to skim past, so we state them plainly on the page rather than only in the footer. The literature the panel was curated from is listed on the references page.

RUO

Research use only

RUO means research use only. CellWise is a software-as-a-medical-device on a clearance pathway and has not been cleared or approved by the FDA. Until SaMD clearance it is for research use, it is not a diagnostic, and it is not intended to diagnose, treat, cure or prevent any disease.

Decision support

It informs a decision, it does not make one

CellWise is decision support for a licensed practitioner. It organizes molecular evidence and shows the reasoning behind every call, including the reasons against. Every diagnostic and treatment decision stays with the clinician and their patient.

What we do not claim

No outcome is promised

Expression is reported against a population baseline whose version is printed on every report, and that baseline grows as samples accumulate, so reported ranges may be revised. CellWise makes no claim that a report is diagnostic, that the baseline is final, or that any clinical outcome will follow.

Help us shape it.

We're onboarding a limited group of design partners to build the platform with. Free proof-of-concept, founder pricing, and a direct line to the team.